As cell therapies transition from the lab to patients’ bedsides, ensuring the highest levels of quality and safety is a significant and critical challenge. PeproTech’s PeproGMP® Cytokines help researchers meet that challenge. Consistent with federal requirements and best practices for cell therapy, gene therapy, and tissue-engineered products for clinical applications, PeproGMP® Cytokines are manufactured and tested in compliance with relevant US FDA GMP (Good Manufacturing Practices) regulations and the ISO 9001 quality management systems standard, without the use of animal-derived materials.
PeproGMP® Cytokines offer safety, purity, and simplified use in ex vivo manufacturing processes, as described in USP (United States Pharmacopeia) Chapter <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products.
All PeproGMP® products are manufactured using animal-derived component free materials.